PHT-427 10mg 10mg | Purity Not Available
Adooq Bioscience
PHT-427 is a novel Akt/phosphatidylinositide-dependent protein kinase 1 pleckstrin homology domain inhibitor.
More Information Supplier PagePHT-427 is a novel Akt/phosphatidylinositide-dependent protein kinase 1 pleckstrin homology domain inhibitor.
More Information Supplier PageCCT128930 is an ATP-competitive AKT inhibitor that is a potent, advanced lead pyrrolopyrimidine compound exhibiting selectivity for AKT over PKA, achieved by targeting a single amino acid difference.
More Information Supplier PageCCT128930 is an ATP-competitive AKT inhibitor that is a potent, advanced lead pyrrolopyrimidine compound exhibiting selectivity for AKT over PKA, achieved by targeting a single amino acid difference.
More Information Supplier PageCCT128930 is an ATP-competitive AKT inhibitor that is a potent, advanced lead pyrrolopyrimidine compound exhibiting selectivity for AKT over PKA, achieved by targeting a single amino acid difference.
More Information Supplier PageCCT128930 is an ATP-competitive AKT inhibitor that is a potent, advanced lead pyrrolopyrimidine compound exhibiting selectivity for AKT over PKA, achieved by targeting a single amino acid difference.
More Information Supplier PageCCT128930 is an ATP-competitive AKT inhibitor that is a potent, advanced lead pyrrolopyrimidine compound exhibiting selectivity for AKT over PKA, achieved by targeting a single amino acid difference.
More Information Supplier PageGSK690693 is a novel ATP-competitive, low-nanomolar pan-Akt kinase inhibitor.
More Information Supplier PageGSK690693 is a novel ATP-competitive, low-nanomolar pan-Akt kinase inhibitor.
More Information Supplier PageGSK690693 is a novel ATP-competitive, low-nanomolar pan-Akt kinase inhibitor.
More Information Supplier PageGeldanamycin binds to the ATP site of Hsp90 (Kd = 1.2 ??M) and inhibits its chaperone activity.
More Information Supplier Page